PORTLAND, Oregon and PUNE, India, January 18, 2017 /PRNewswire/ --
A new report published by Allied Market Research, titled, "Breast Imaging Technologies Market by Type: Global Opportunity Analysis and Industry Forecast, 2014-2022," projects that the global breast imaging technologies market size was valued at $2,544 million in 2015 and is expected to reach $4,502 million by 2022, growing at a CAGR of 8.4% from 2016 to 2022. North America and Europe together accounted for over three-fourths market share in 2015. Ionizing breast imaging technology is expected to maintain its lead throughout the forecast period.
Summary of the Breast Imaging Technology Market Report can be accessed on the website at:
The market is expected to be driven by the rise in incidence of breast cancer globally, favorable reimbursement policies, and growth in geriatric population base. Moreover, technological advancements, such as 3D mammography, which help in the detection of breast cancer in women with dense breast tissues, boost the market growth. However, high cost of these imaging modalities and stringent regulatory approval processes are set to restrict the market growth.
Request for Sample: https://www.alliedmarketresearch.com/request-free-sample/886
According to Hemali Narkhede, Manager, Healthcare Research at Allied Market Research, "Proactive initiatives by healthcare organizations to raise awareness are set to increase the demand for breast imaging technologies worldwide." "These initiatives help individuals to gain information about the availability of imaging technologies, which can be used for the screening and diagnosis of breast cancers, thus boosting the market growth," she further added.
Ionizing breast imaging technologies market accounted for major share of the global market in 2015, owing to their ability to detect breast cancer in early stages, thus increasing the chances of survival. Moreover, advancements in breast imaging tools facilitate faster interpretation of breast tissue and generate less false positive results as compared to MRI, which further accelerates the market growth. Non-ionizing imaging technologies are projected to grow with the highest CAGR, due to the introduction of better imaging modalities such as automated whole breast ultrasound system (ABUS). In addition, unlike ionizing breast imaging technologies, these techniques use infrared radiations, reducing the risk of developing radiation-induced cancer, which is thus anticipated to witness an increased demand in future.
Full-field digital mammography systems segment contributed for the major market share in 2015, as the technique is time efficient and utilizes a lesser radiation dose than film mammography. Moreover, the radiologists can adjust the darkness or brightness of the breast image due to which it is easier to observe differences between breast tissues in digital mammography. 3D breast tomosynthesis segment is projected to grow at the fastest rate during the forecast period, as this imaging technology facilitates easy detection of breast cancer in women with dense breast tissues.
Breast MRI segment dominated the non-ionizing breast imaging technologies market in 2015, owing to the associated benefits such as visualization of the breast in any orientation, which makes it highly sensitive to small abnormalities; while the breast ultrasound is anticipated to grow with the highest CAGR from 2016 to 2022.
Summary of similar reports can be viewed at: https://www.alliedmarketresearch.com/life-sciences/medical-devices-market-report
Key findings of the Breast Imaging Technology Market study:
- The ionizing breast imaging segment accounted for almost two-thirds of the total market in 2015, while non-ionizing breast imaging technologies is expected to be the fastest growing segment, recording a CAGR of 9.2% during the forecast period.
- Full-field digital mammography system accounted for more than three-fourths of the total ionizing breast imaging technologies market in 2015.
- 3D breast tomosynthesis segment is expected to grow with the highest CAGR of 9.9%.
- Among non-ionizing breast imaging technologies, breast MRI accounted for nearly two-fifths of the total market share in 2015. On the other hand, breast ultrasound is poised to grow at a faster rate at a CAGR of 9.9%.
- Asia-Pacific is expected to expand at the highest CAGR of 9.5%.
North America was the highest revenue contributor to the global revenue in 2015 and is expected to maintain this trend throughout the forecast period. This is due to the rise in incidence of breast cancer, growth in awareness among patients regarding better breast imaging modalities, and availability of advanced healthcare facilities.
The key players profiled in this report include Dilon Technologies, Inc., FUJIFILM Holdings Corporation, Gamma Medica, Inc., General Electric Company, Hologic, Inc., Koning Corporation, Koninklijke Philips N.V., Siemens AG, Sonociné, Inc., and Toshiba Corporation.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1 (800) 792-5285 (U.S. & Canada)
Fax: +1 (855) 550-5975
SOURCE Allied Market Research